Navigenics Inc, a personal genomics company, has raised $18m from consumer products player The Procter and Gamble Company. Existing investors Kleiner Perkins Caufield and Byers and Mohr Davidow Ventures also participated in this series C round.
Navigenics was set up with the goal of improving health outcomes in individuals by educating them and their physicians with knowledge of their genetic predispositions so they can act on the information to prevent the onset of disease, achieve earlier diagnosis, appropriately manage disease, or otherwise lessen its impact.
“I welcome the partnership of Procter and Gamble. Their extraordinary track record of consumer understanding provides Navigenics with an unparalleled opportunity to understand and serve the needs of our customers,” said Vance Vanier, Navigenics president and CEO. “When combined with their commitment to developing innovative consumer health and wellness products and an expanding focus on health services, P&G’s insight and brand will strengthen Navigenics’ position to embed personal genomics into the prevention dialogue of everyday healthcare.”
Since its founding in 1972, venture capital firm Kleiner Perkins Caufield & Byers has backed AOL, Amazon.com, Citrix, Compaq Computer, Electronic Arts, Genentech, Genomic Health, Google, Intuit, Juniper Networks, Netscape, Lotus, Sun Microsystems, Symantec, Verisign and Xilinx.
Companies funded by Mohr Davidow Ventures include Actuate, Agile, Auspex, Broadbase, Brocade, Epigram, FormFactor, Freshwater Software, Ipsilon Networks, Kalpana, Numerical Technologies, ONI Systems, Pivotal Technologies, Rambus, Vantive, Vitesse and Zip2.
Copyright © 2010 AltAssets